[1] GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol 2019;18(5):459 − 80. http://dx.doi.org/10.1016/s1474-4422(18)30499-xCrossRef
[2] Jia LF, Du YF, Chu L, Zhang ZJ, Li FY, Lyu DY, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health 2020;5(12):e661 − 71. http://dx.doi.org/10.1016/S2468-2667(20)30185-7CrossRef
[3] Eshkoor SA, Hamid TA, Mun CY, Ng CK. Mild cognitive impairment and its management in older people. Clin Interv Aging 2015;10:687 − 93. http://dx.doi.org/10.2147/cia.S73922CrossRef
[4] Zeng Y. Towards deeper research and better policy for healthy aging-using the unique data of Chinese longitudinal healthy longevity survey. Chin Econom J 2012;5(2 − 3):131 − 49. http://dx.doi.org/10.1080/17538963.2013.764677CrossRef
[5] Cui GH, Yao YH, Xu RF, Tang HD, Jiang GX, Wang Y, et al. Cognitive impairment using education-based cutoff points for CMMSE scores in elderly Chinese people of agricultural and rural Shanghai China. Acta Neurol Scand 2011;124(6):361 − 7. http://dx.doi.org/10.1111/j.1600-0404.2010.01484.xCrossRef
[6] Hoogendijk EO, Stolz E, Oude Voshaar RC, Deeg DJH, Huisman M, Jeuring HW. Trends in frailty and its association with mortality: results from the longitudinal aging study amsterdam, 1995–2016. Am J Epidemiol 2021;190(7):1316 − 23. http://dx.doi.org/10.1093/aje/kwab018CrossRef
[7] Richardson C, Stephan BCM, Robinson L, Brayne C, Matthews FE. Two-decade change in prevalence of cognitive impairment in the UK. Eur J Epidemiol 2019;34(11):1085 − 92. http://dx.doi.org/10.1007/s10654-019-00554-xCrossRef
[8] Ribeiro FS, de Oliveira Duarte YA, Santos JLF, Leist AK. Changes in prevalence of cognitive impairment and associated risk factors 2000-2015 in São Paulo, Brazil. BMC Geriatr 2021;21(1):609. http://dx.doi.org/10.1186/s12877-021-02542-xCrossRef
[9] Zhang ZM. Gender differentials in cognitive impairment and decline of the oldest old in China. J Gerontol: Ser B 2006;61(2):S107 − 15. http://dx.doi.org/10.1093/geronb/61.2.s107CrossRef
[10] Guo S, Liu SJ, Xiao YM, Song XM. Trends in the prevalence of cognitive impairment among the Chinese elderly: the effect of rising levels of education. Disabil Res 2021;(2):74-80. https://d.wanfangdata.com.cn/periodical/ChlQZXJpb2RpY2FsQ0hJTmV3UzIwMjIwOTAxEg5janJ5ajIwMjEwMjAwOBoIM3oxZXFuYms%253D. (In Chinese). https://d.wanfangdata.com.cn/periodical/ChlQZXJpb2RpY2FsQ0hJTmV3UzIwMjIwOTAxEg5janJ5ajIwMjEwMjAwOBoIM3oxZXFuYms%253D
[11] Kuang WH, Gao MY, Tian LT, Wan Y, Qiu PY. Trends in the prevalence of cognitive impairment in Chinese older adults: based on the Chinese Longitudinal Healthy Longevity Survey cohorts from 1998 to 2014. Int Health 2020;12(5):378 − 87. http://dx.doi.org/10.1093/inthealth/ihz114CrossRef
[12] Xue J, Li JR, Liang JM, Chen SL. The prevalence of mild cognitive impairment in China: a systematic review. Aging Dis 2018;9(4):706 − 15. http://dx.doi.org/10.14336/ad.2017.0928CrossRef
[13] Laws KR, Irvine K, Gale TM. Sex differences in cognitive impairment in Alzheimer’s disease. World J Psychiatry 2016;6(1):54 − 65. http://dx.doi.org/10.5498/wjp.v6.i1.54CrossRef
[14] McGrattan AM, Zhu YP, Richardson CD, Mohan D, Soh YC, Sajjad A, et al. Prevalence and risk of mild cognitive impairment in low and middle-income countries: a systematic review. J Alzheimers Dis 2021;79(2):743 − 62. http://dx.doi.org/10.3233/jad-201043CrossRef
[15] Gillis C, Mirzaei F, Potashman M, Ikram MA, Maserejian N. The incidence of mild cognitive impairment: a systematic review and data synthesis. Alzheimers Dement (Amst) 2019;11(1):248 − 56. http://dx.doi.org/10.1016/j.dadm.2019.01.004CrossRef
[16] Madley-Dowd P, Hughes R, Tilling K, Heron J. The proportion of missing data should not be used to guide decisions on multiple imputation. J Clin Epidemiol 2019;110:63 − 73. http://dx.doi.org/10.1016/j.jclinepi.2019.02.016CrossRef